Trans-Tympanic Nanoparticle Delivery for Localized Middle Ear Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for otitis media, particularly in children, involve systemic oral administration of antimicrobial agents, leading to resistance and adverse side effects, with few non-invasive alternatives, and surgical intervention being common due to the impermeability of the tympanic membrane.
Innovation Solution
Development of cationic, anionic, and polymer-based nanoparticles for topical application in the ear canal, which diffuse through the tympanic membrane to deliver therapeutic agents directly to the middle ear, avoiding systemic exposure.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If systemic oral antimicrobial agents are used to treat otitis media, then the infection is treated, but adverse side effects and drug resistance occur
Solution Approach 1:
The patent applies local quality by formulating nanoparticles with specific surface charges (cationic, anionic, or neutral) and compositions that are selectively delivered to the middle ear cavity. The nanoparticles are designed with specific properties (size, charge, composition) that enable them to penetrate the tympanic membrane and accumulate in the middle ear, providing localized treatment without systemic exposure. This resolves the contradiction by maintaining treatment effectiveness while eliminating adverse side effects and drug resistance associated with systemic antibiotics.
Solution Approach 2:
The patent uses nanoparticles as an intermediary carrier system to deliver therapeutic agents across the tympanic membrane. The nanoparticles serve as a mediator that facilitates the transport of antimicrobial and anti-inflammatory drugs from the ear canal into the middle ear cavity, bypassing the need for systemic administration. This intermediary approach enables targeted delivery while avoiding the harmful effects of systemic drug exposure.
2Reliability
If surgical intervention with tympanostomy tube placement is performed, then chronic otitis media is treated, but invasive procedures are required
Solution Approach 1:
The patent replaces the mechanical surgical intervention (tympanostomy tube placement) with a chemical/nanoparticle-based delivery system. Instead of mechanically opening the ear drum to access the middle ear, the nanoparticles chemically penetrate the intact tympanic membrane through charge-mediated interactions and membrane permeation. This substitution eliminates the need for invasive surgery while providing effective treatment for chronic otitis media.
Solution Approach 2:
The patent utilizes parameter changes in nanoparticle properties (surface charge, size, composition) to enable penetration of the tympanic membrane. By adjusting these parameters, the nanoparticles can efficiently cross the membrane barrier without surgical assistance. This parameter optimization allows non-invasive delivery while maintaining treatment effectiveness, replacing the need for surgical intervention.
3Ease of manufacture
If the tympanic membrane is considered impermeable, then topical delivery is ineffective, but nanoparticles can diffuse through it
Solution Approach 1:
The patent changes the parameters of the delivery system by using nanoparticles with specific size (nanoscale dimension) and surface charge properties. These parameter changes enable the nanoparticles to penetrate the tympanic membrane, which is impermeable to conventional larger molecules. The nanoscale size and charged surface allow the particles to interact with and pass through the membrane structure, transforming an impermeable barrier into a penetrable pathway.
Solution Approach 2:
The nanoparticles act as an intermediary that bridges the gap between topical application and middle ear delivery. They facilitate the transition from ear canal application to middle ear cavity penetration by mediating the interaction with the tympanic membrane. This intermediary system overcomes the membrane's impermeability while maintaining the simplicity of topical delivery administration.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid, localized delivery of therapeutic agents to the middle ear, reducing off-target effects and achieving effective drug levels without altering the membrane's integrity, offering a non-invasive alternative to oral treatments.
Implementation Method 1
the topically applied nanoparticles diffuse through the ear's tympanic membrane, thereby delivering the one or more therapeutic agents to the middle ear
Data Source
AI summary
Provided herein are methods and compositions for trans-tympanic membrane delivery of therapeutic agents such as antimicrobial agents, anti-inflammatory agents, and anti-biofilm agents to the middle or inner ear for rapid, localized treatment and prevention of diseases and conditions associated with a middle ear infection. In particular, provided herein are anionic and polymer-based nanoparticles that provide a platform for delivery of therapeutic cargo, as well as anionic and polymer-based nanoparticle compositions for rapid, localized delivery of therapeutic agents to the middle or inner ear.